PEOPLE - SELECT Therapeutics makes appointment:
This article was originally published in Clinica
Executive Summary
The chairman of SELECT Therapeutics has announced the appointment of Andrew Muir as CEO and director. Dr Muir possesses over 30 years of management experience and is a member of the board of directors for several private technology companies. The vice-chairman of the board has been named as Thomas Reardon, who has been with the company since 1999. Steve Peltzman has resigned as CEO.